Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
2/18/2025
WuXi XDC in Strategic Transformation through Ownership Shift and Capit...
2/18/2025
NovoCodex's ARX788 Demonstrates Efficacy in HER2-Positive Advanced Bre...
2/18/2025
BioKin Initiates Phase III Trial in China for BL-B01D1 in NSCLC
2/18/2025
Huadong Medicine Announces Positive Results from HDM1005 Clinical Tria...
2/18/2025
META Pharmaceuticals Completes Series A1 Financing Led by XtalPi
2/18/2025
Polymed Licenses IRAK4-Targeting Protein Degrader HPB-143 to Photys
2/18/2025
Zydus Partners with Beihai to Launch BEIZRAY in the U.S.
2/18/2025
QL Biopharma Secures ¥100M Series C Financing to Advance Treatments f...
2/17/2025
China's Retail Pharmacy Market Reaches CNY 574 Billion in 2024 Amid Sl...
2/17/2025
Aurobindo Pharma to Begin European Supplies from China Facility in Apr...
2/17/2025
Betta Pharma's Xcovery Initiates EMA Approval Process for Ensartinib i...
2/17/2025
BioNTech Initiates Phase 1/2 Trial for BNT327 and BNT323 Combination i...
2/17/2025
CSPC's SYS6005 ADC Enters Phase I Clinical Trials in China
2/14/2025
Recent Executive Moves
2/14/2025
CDE Issues on the Guidelines for Clinical Trial Design of New Drugs fo...
2/14/2025
China Launches Hotlines, Awareness Campaigns to Bolster Mental Health ...
2/14/2025
China's Health Insurance Premiums Reached $134B in 2024, Up 8.2% YoY
2/14/2025
National Health Commission to Implement Eight Key Healthcare Initiativ...
2/14/2025
China Approves Novo Nordisk's Semaglutide Injection for New Indication
2/14/2025
NMPA Approves Sinocelltech's Finotonlimab for R/M HNSCC
2/14/2025
Trinomab's TNM002: A New Passive Immunization Agent for Emergency Teta...
2/14/2025
NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
2/13/2025
GSK's Mepolizumab Submits New COPD Indication for Market Approval in C...
2/13/2025
Over 30 Listed Chinese Pharma Firms Report First-Time Losses as 257 Co...
2/13/2025
China's Pharmaceutical Market Shrinks in 2024 Amid Structural Shifts
2/13/2025
China Overtakes U.S. in Annual Clinical Trials: GlobalData
2/13/2025
Jiangsu Recbio's Novel HPV Vaccine Trial Approved in China
2/13/2025
Global PE Firms Compete to Acquire Majority Stake in Gland Pharma from...
2/12/2025
Lion TCR's Liocyx-M004 Receives FDA IND Approval for Phase 2 Trial
2/12/2025
CDE Issues the List of Reference Formulations for GQCE Studies (90th B...
Page:
11
/
48
Total number of articles:
1434
:
[First]
[<<]
[9]
[10]
[11]
[12]
[13]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit